feed,title,long_url,short_url
MarketWatch,Oramed Pharmaceuticals started at buy with $27 stock price target at Canaccord Genuity,http://feeds.marketwatch.com/~r/marketwatch/realtimeheadlines/~3/Kw0M_RDw2Vc/quotes.asp,https://on.mktw.net/3dwKlVN
